| |
| |
|
| Insider
Information: |
Stapleton Craig R |
| Relationship: |
Former 10% Owner |
| City: |
Greenwich |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
812,271 |
|
|
Indirect Shares
|
2,658,665 |
|
|
| Direct
Value |
$13,055,014 |
|
|
|
Indirect Value
|
$314,781,343 |
|
|
| Total
Shares |
3,470,936 |
|
|
| Total
Value |
$327,836,357 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sonomawest Holdings Inc |
SWHI |
See Remarks, Director,... |
2009-02-20 |
376,645 |
2011-06-23 |
550,601 |
Premium* |
|
|
T-Mobile Us Inc |
TMUS |
Director |
|
0 |
2004-07-28 |
1,864,800 |
Premium* |
|
|
Abercrombie & Fitch Co |
ANF |
Director |
2016-09-01 |
57,398 |
2010-02-18 |
0 |
Premium* |
|
|
AVADEL Pharmaceuticals Plc |
AVDL |
Director |
2018-08-01 |
378,228 |
2018-08-01 |
210,400 |
Premium* |
|
|
Reata Pharmaceuticals Inc |
RETA |
Former 10% Owner |
2016-06-09 |
0 |
2016-06-09 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2018-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
27,900 |
378,228 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2018-07-09 |
4 |
A |
$0.00 |
$0 |
D/D |
57,315 |
350,328 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-12-15 |
4/A |
B |
$8.67 |
$606,970 |
I/I |
70,000 |
180,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-12-15 |
4/A |
B |
$8.67 |
$606,970 |
D/D |
70,000 |
323,413 |
2.39 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-12-15 |
4 |
A |
$8.67 |
$606,970 |
I/I |
70,000 |
180,000 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-12-15 |
4 |
A |
$8.67 |
$606,970 |
D/D |
70,000 |
323,413 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-11-27 |
4 |
S |
$9.35 |
$2,377,632 |
D/D |
(254,265) |
253,413 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-09-12 |
4 |
B |
$9.52 |
$190,360 |
I/I |
20,000 |
110,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-22 |
4 |
B |
$9.76 |
$164,944 |
I/I |
16,900 |
90,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-19 |
4 |
B |
$9.83 |
$30,473 |
I/I |
3,100 |
73,100 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-18 |
4 |
B |
$9.98 |
$109,910 |
I/I |
11,013 |
70,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-17 |
4 |
A |
$9.95 |
$120,393 |
I/I |
12,100 |
58,987 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-16 |
4 |
A |
$10.00 |
$34,700 |
I/I |
3,470 |
46,887 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-15 |
4 |
A |
$10.00 |
$3,110 |
I/I |
311 |
43,417 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-05-12 |
4 |
A |
$10.00 |
$31,060 |
I/I |
3,106 |
43,106 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-04-04 |
4 |
A |
$9.58 |
$143,643 |
D/D |
15,000 |
507,678 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
I/I |
56,200 |
16,200 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
492,678 |
492,678 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-31 |
4 |
D |
$0.00 |
$0 |
I/I |
(56,200) |
0 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(492,678) |
0 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
27,000 |
492,678 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-19 |
4 |
GA |
$0.00 |
$0 |
I/I |
29,700 |
16,200 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-12-19 |
4 |
GD |
$0.00 |
$0 |
I/I |
13,500 |
26,500 |
0 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-11-29 |
4 |
B |
$10.85 |
$108,500 |
I/I |
10,000 |
40,000 |
2.1 |
- |
|
| AVDL |
AVADEL Pharmaceuticals Pl... |
Director |
– • – |
2016-11-28 |
4 |
B |
$10.74 |
$107,370 |
I/I |
10,000 |
30,000 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
